![]() |
Volumn 375, Issue 16, 2016, Pages 1591-1592
|
Adaptive randomization of neratinib in early breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NERATINIB;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
QUINOLINE DERIVATIVE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL EFFECTIVENESS;
DRUG EFFICACY;
DRUG RESPONSE;
EARLY CANCER;
HUMAN;
LETTER;
PRIORITY JOURNAL;
BREAST NEOPLASMS;
RANDOMIZATION;
BREAST NEOPLASMS;
HUMANS;
QUINOLINES;
RANDOM ALLOCATION;
RECEPTOR, ERBB-2;
|
EID: 84992028261
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1609993 Document Type: Letter |
Times cited : (10)
|
References (4)
|